Home » Topics » BioWorld Science

BioWorld Science
RSS

Sweet taste of success for asymmetric organocatalysis

Oct. 6, 2021

Q-State announces ASO discovery programs targeting neurodegenerative disorders

Oct. 6, 2021

A global structural and competitive landscape of key antibody binding sites on SARS-CoV-2 spike

Oct. 6, 2021

Reduced Shh signaling is involved in the formation and expression of levodopa-induced dyskinesia

Oct. 6, 2021

89Zr immune PET/CT improves response assessment in murine model of lung cancer under immunotherapy

Oct. 6, 2021

Discovery of novel thiazolidinedione derivatives that inhibit HBV internalization

Oct. 6, 2021

[18F]-TFB radiotracer useful for PET imaging of glioblastoma

Oct. 6, 2021

Targeting Th17 and cdT17 function protects against ICI-induced autoimmune thyroiditis

Oct. 6, 2021

TYK Medicines discovers new EGFR and/or HER2 mutant inhibitors

Oct. 6, 2021

VRDN-001 potently inhibits IGF-1R signaling in vitro

Oct. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...